Tag: fiscal

AMSC Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Outlook

AMSC

AMSC

Company to host conference call tomorrow, August 10 at 10:00 am ET

AYER, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) — AMSC (Nasdaq: AMSC), a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid™ and protect and expand the capability and resiliency of our Navy’s fleet, today reported financial results for its first quarter of fiscal year 2023 ended June 30, 2023.

Revenues for the first quarter of fiscal 2023 were $30.3 million compared with $22.7 million for the same period of fiscal 2022. The year-over-year increase was driven primarily by higher new energy power systems revenues, versus the year ago period.

AMSC’s net loss for the first quarter of fiscal 2023 was $5.4 million, or $0.19 per share, compared to a net loss of $8.7 million, or $0.32 per share, for the same period of fiscal 2022.  The Company’s non-GAAP net loss for the first quarter of fiscal 2023 was $2.1 million, or $0.08 per share, compared with a non-GAAP net loss of $6.8 million, or $0.25 per share, in the same period of fiscal 2022. Please refer to the financial table below for a reconciliation of GAAP to non-GAAP results.

Cash, cash equivalents, and restricted cash on June 30, 2023, totaled $23.1 million, compared with $25.7 million at March 31, 2023.

“Fiscal 2023 is off to a good start with first quarter revenues exceeding our expectations. Solid execution on strong demand from our new energy power systems and Navy markets drove revenue for the quarter. Additionally, stronger margins drove a narrowed cash burn,” said Daniel P. McGahn, Chairman, President and CEO, AMSC. “During the quarter, we booked over $34 million of new energy power systems orders across a diversity of end markets including new military applications, which provide 

Read More ...

Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023

Nemaura Medical, Inc

Nemaura Medical, Inc

Loughborough, England, July 14, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today provides a business update and financial results for the fiscal year ended March 31, 2023.

Corporate Highlights:

 

 

  • Entered into a Registered Direct Offering and concurrent Private Placement for gross proceeds of approximately $8.4 million (before expenses).

  • Signed a preliminary agreement with Eversana to support a planned commercial launch of its Diabetes and Metabolic Health programs in the USA.

  • Announced initial patient data from UK NHS (National Health Service) Miboko Study that thus far demonstrated weight loss in 100% of participants, with further studies ongoing. The data is expected to support reimbursement applications and product marketing in various territories.

  • Continued to work with Benchmark Electronics Inc as a contract manufacturing partner (CMO) to facilitate future volume scale-up manufacture of the electronic transmitter at its FDA approved facility in Thailand, in anticipation of commercial-sales ramp-up.

  • Completed phased delivery of transmitters against the purchase order received from MSW in December 2021.

  • Received a provisional purchase order for 1.7 million sensors from its licensee TPMENA in anticipation of product registration in the KSA.

“We continue to build momentum on both manufacturing activities and consumer feedback through pilot trials, in preparation for scaling up commercial sales activities. The trials with the NHS in the UK have demonstrated the commercial potential for our sensors and digital health and wellbeing programs and has allowed us to undertake continuous refinements prior to commercial scale-up initiatives. Similarly, we believe working with world-class contract manufacturers and advancing our manufacture scale-up, and ensuring a well-managed supply chain through forward planning will support our planned commercial endeavours”, commented Dr Faz

Read More ...

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023

  • The Company achieved revenue of $20.7 million during the year ended April 30, 2023, a 6.7% increase from the year ended April 30, 2022. YoY growth increases to 9.0% when adjusting for the effects of currency translation.

  • The Company recorded total revenue of $5.6 million during the three months ended April 30, 2023, the highest quarterly revenue total the Company has recorded.

VICTORIA, British Columbia, July 07, 2023–(BUSINESS WIRE)–IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced financial results for the full fiscal year 2023 ended April 30, 2023.

“As we usher in Fiscal Year 2024, we carry with us a strong momentum from the impressive strides we made in the previous year. In the fiscal year ended April 30, 2023, we achieved a revenue of $20.7 million, marking a notable 6.7% (or 9% when adjusting for the effects of currency translation) increase compared to the year ended April 30, 2022. We also recorded our highest quarterly revenue total of $5.6 million in the last quarter ending April 30, 2023. These milestones serve as a testament to the soundness of our strategies and the dedication of our team.

As we look ahead to Fiscal Year 2024, we see immense potential for our in silico suite of services and data management capabilities to further bolster our growth. We expect these innovative offerings to significantly contribute to our financial performance this year and set the stage for long-term success.

Our unwavering commitment to excellence, coupled with our robust pipeline and agile execution, position us to deliver continued strong performance this year and beyond. This is a thrilling period for our company, and we are eager to embark on the new fiscal year, further driving innovation and growth.” Stated Dr.

Read More ...

IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023

Article content

  • IPA’s Project revenue increased by 16.7% compared to the prior year, driven by the growth of the company’s proprietary B cell Select® platform and protein manufacturing services.
  • Talem Therapeutics has announced a collaboration with Libera Bio to develop multi-target antibodies including the use of artificial intelligence (AI) technology. The companies will use Talem’s AI platform to help discover and optimize antibodies for various diseases, including cancer. This collaboration is expected to generate antibodies against disease targets that have historically been undruggable.
  • BriaCell’s AI-based drug discovery program, after a brief pause due to additional workflows added, is underway and going well. The program is using BioStrand’s LENSai to analyze and prioritize potential drug targets for cancer treatment. BriaCell aims to use this technology to accelerate the development of new cancer therapies.
  • BioStrand announces the first monetization of its Natural Language Processing (NLP) and immunogenicity modules. These modules are now allowing pharmaceutical companies to extract and analyze data from scientific publications and identify potential immunogenicity issues with drug candidates. BioStrand is ramping its efforts to use this technology to help pharmaceutical companies develop safer and more effective drugs.
  • BioStrand’s SAAS-based data management platform has been awarded a first-round RFP (Request for Proposal) by an undisclosed pharmaceutical company. The platform allows researchers to store, manage, and analyze large amounts of genomic, transcriptomic, and proteomic data using AI and HYFTs technology. If awarded, this program is expected to help the pharmaceutical company accelerate
Read More ...

China to deepen fiscal reform, open up to much more foreign investment – Business enterprise

&#13
&#13
&#13&#13&#13
China to deepen financial reform, open to more foreign investment&#13

Organization

&#13
&#13

China has stepped up its attempts to cope with fiscal risks as the economy grew by just 3 for every cent

&#13
&#13
&#13
&#13

&#13
&#13
&#13
&#13
&#13

&#13
&#13

BEIJING/SHANGHAI (Reuters) – China will deepen money reform and increase its regulatory routine to guard against dangers to the economic system, and further more open up up to foreign financial commitment, Premier Li Keqiang mentioned on Sunday.

&#13

The government will fend off dangers for substantial-high quality house corporations and minimize the load of fascination payments for neighborhood governments, the outgoing premier claimed in his function report to the opening of the annual assembly of China’s parliament. 

&#13

“We want to deepen reform of the economic method, enhance fiscal regulation, and see that all people included presume their total obligations to guard versus regional and systemic money dangers,” the premier reported.

&#13

China has stepped up its efforts to cope with monetary dangers as the economic climate grew by just 3 for each cent previous yr, a single of its worst showings in a long time. The economic climate was squeezed by three yrs of Covid limits, a crisis in its home sector, a crackdown on personal organization and weakening demand from customers for Chinese exports.

&#13

The leading also gave increased emphasis to institutional reform when compared with last yr. This came just after state media reviews on Tuesday that President Xi Jinping designs for an “intense” and “broad-ranging” re-organisation of state-owned enterprises (SOEs) and Communist Bash entities.

&#13

Xi, who secured a precedent-breaking third management term in October, is organizing to resurrect the Central Fiscal Get

Read More ...

Dell Technologies Delivers Fourth Quarter and Full Year Fiscal 2023 Financial Results

News summary

  • Record full-year revenue of $102.3 billion, up 1%, and fourth quarter revenue of $25 billion, down 11%
  • Record full-year operating income of $5.8 billion, up 24%, and record non-GAAP operating income of $8.6 billion, up 11%
  • Full-year diluted earnings per share at $3.24, and non-GAAP diluted earnings per share at $7.61
  • Announcing a 12% increase in annual cash dividend to $1.48 per common share

ROUND ROCK, Texas, March 2, 2023 /PRNewswire/ — 

Full story
Dell Technologies (NYSE: DELL) announces financial results for its fiscal 2023 fourth quarter and full year. Revenue for the year was a record $102.3 billion, up 1% over fiscal year 2022. The company generated record operating income of $5.8 billion, up 24% over the prior year, and record non-GAAP operating income of $8.6 billion, up 11%. For the full year, net income from continuing operations was $2.4 billion and non-GAAP net income was $5.7 billion. Cash flow from operations was $3.6 billion. Full-year diluted earnings per share from continuing operations was $3.24, and non-GAAP diluted earnings per share was $7.61.

Fourth quarter revenue was $25 billion, down 11%. Operating income was $1.2 billion, representing 4.7% of revenue, and non-GAAP operating income was $2.2 billion, representing 8.7% of revenue. Net income from continuing operations for the quarter was $606 million, and non-GAAP net income was $1.3 billion. Cash flow from operations for the quarter was $2.7 billion. Diluted earnings per share from continuing operations was $0.84, and non-GAAP diluted earnings per share was $1.80.

Dell ended the quarter with remaining performance obligations of $40 billion, deferred revenue of $30.3 billion and recurring revenue of approximately $5.6 billion, up 12% year-over-year. Cash

Read More ...

India’s fiscal sector regulators are seized of the issue: FM

Amid concerns in excess of the ongoing controversy associated to the Adani team, Union Finance Minister Nirmala Sitharaman on Saturday mentioned the country’s fiscal sector regulators are seized of the make a difference and have been usually on their toes, not just now.
“India’s regulators, and I am sitting down in the firm of a extremely senior regulator, just one of the oldest regulators…India’s regulators are quite, quite experienced. And they are experts in their area. The regulators are relatively seized of this issue. They are on their toes, as always, and not just now,” Sitharaman said in a press briefing following the 600th meeting of the Central Board of Directors of Reserve Lender of India (RBI).

The minister’s responses arrive a day immediately after the Supreme Court docket asked the Centre and market place regulator Securities and Exchange Board of India (SEBI) to suggest steps to fortify the regulatory mechanism and secure Indian buyers from sector volatility like the just one witnessed in the wake of the Hindenburg Research report on the Adani Group. When asked about the government’s response on the petition in the SC, Sitharaman did not give specifics and mentioned the response of the govt will be outlined in the court docket.

A a few-decide bench, headed by Main Justice of India D Y Chandrachud, on Friday experienced pointed out that the stock market place has viewed the increasing existence of the middle-course and there was a require, therefore, to scale up protection measures in tune with India’s shifting status on the earth stage.

Nevertheless, it also stated that it was not “planning any witch-hunt” and would tread with “very wonderful caution” as its observations would have an impact on the inventory marketplace which “goes mainly by sentiments”.

The bench was hearing two petitions: 1 in

Read More ...

It is time to slice Russia out of the global fiscal method

The author is Ukraine’s minister of finance

In the aftermath of the chilly war, environment powers put in position systems of world wide governance. The objective was to guard liberal values, human legal rights and the world overall economy, and to extinguish the risk of nuclear annihilation.

The unquestionable achievements of this new rules-dependent global order was its reach, bringing in Russia and publish-Soviet Union states as nicely as other burgeoning economies these types of as China and India.

But these types of a method only operates when its members adhere to the rules. With its violent and unprovoked invasion of Ukraine, toxic support of corruption and documented financing of terrorism, Vladimir Putin’s Russia tends to make a full mockery of the guidelines-based mostly worldwide buy that gave us a distinctive period of time of peace and economic advancement.

Still, irrespective of every little thing, Russia maintains a foothold in the world process it is carrying out every little thing it can to undermine. Russia sits on the UN Stability Council and other UN bodies. The Stability Council was produced with the unique aim of blocking wars. How, then, can Russia continue to be a member just after embarking on its war of aggression in opposition to Ukraine?

We also have an global entire body to make certain world-wide economic protection — the Money Action Task Pressure. Developed by the G7, the FATF sets criteria and promotes powerful implementation of authorized, regulatory and operational steps to limit 3 main hazards: funds laundering, funding of terrorism and of the proliferation of weapons of mass destruction.

Today, FATF has 37 member states. These incorporate Russia, inspite of evidence of the nation failing to satisfy FATF requirements on all three fronts.

This thirty day period, FATF associates will obtain in Paris to look

Read More ...